Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified May 2010 by Seoul National University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
Seoul National University Hospital
ClinicalTrials.gov Identifier:
NCT01121068
First received: May 9, 2010
Last updated: May 11, 2010
Last verified: May 2010

May 9, 2010
May 11, 2010
May 2010
May 2011   (final data collection date for primary outcome measure)
Results of interferon-gamma releasing assay [ Time Frame: monthly for 1 year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT01121068 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Monthly Follow up of Interferon Gamma Releasing Assay (IGRA) Among Health-care Workers Treating Tuberculosis (TB) Patients
Monthly Follow up of Interferon Gamma Releasing Assay Among Health-care Workers Treating TB Patients

Interferon gamma releasing assay(IGRA) is useful to diagnose latent tuberculosis. However,IGRA responses could show within-subject variability. We wanted to determine long-term IGRA variability in health-care workers who continuously expose to tuberculosis patients.

IGRA will be performed monthly in health-care workers with continuous exposure to tuberculosis patients for 1 year.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

Health care workers who are continuously exposed to TB patients

Tuberculosis
Other: Blood samplings
About 3.5ml of blood will be drawn from the participants monthly.
Health care workers
Intervention: Other: Blood samplings
Park JS, Lee JS, Kim MY, Lee CH, Yoon HI, Lee SM, Yoo CG, Kim YW, Han SK, Yim JJ. Monthly follow-ups of interferon-γ release assays among health-care workers in contact with patients with TB. Chest. 2012 Dec;142(6):1461-8.

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruiting
25
December 2011
May 2011   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Health care workers who are continuously exposed to TB patients Age > 20 years

Exclusion Criteria:

  • Pregnant Active TB Use of immunosuppressants
Both
20 Years and older
Yes
Contact: Jae-Joon Yim, MD. +82-2-2072-2059 yimjj@snu.ac.kr
Contact: Jong Sun Park, MD jspark.im@gmail.com
Korea, Republic of
 
NCT01121068
monthly IGRA
No
Jae-Joon Yim, Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Seoul National University Hospital
Not Provided
Study Chair: Jae-Joon Yim, MD Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine
Seoul National University Hospital
May 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP